Skip to content

Performance Evaluation by the User of BGM Contour Care According to ISO 15197:2015

Leistungsbewertung Durch Den Anwender. Evaluierung Des Blutglukose Monitoring Systems Contour Care Der Firma Ascensia gemäß DIN EN ISO 15197:2015

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06937736
Enrollment
101
Registered
2025-04-22
Start date
2024-06-20
Completion date
2024-07-23
Last updated
2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

Performance Evaluation by the User of the Blood Glucose Monitoring SystemContour Care in accordance with DIN EN ISO 15197:2015

Interventions

blood glucose measurement by subject using finger tip capillary blood

Sponsors

Institut fur Diabetes Karlsburg GmbH
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female patients with clinical indication for blood glucose measurements (i.e. Diabetes mellitus) * Male or female patients with hypo-, eu- or hyperglycemia * The written informed consent had to be signed * The volunteers must be older than 18 years * The volunteers have legal capacity and are able to understand meaning, nature and possible consequences of the procedures involved

Exclusion criteria

* Pregnancy or lactation * Acute or chronic diseases that * pose a risk of aggravation by the measure * pose a health hazard to the personnel * A current constitution that does not allow participating in the study * Participation in another study or activity with the blood glucose measuring system evaluated in the present study * Application of substances listed in Appendix A of DIN EN ISO 15197:2015

Design outcomes

Primary

MeasureTime frameDescription
Analysis of system accuracy based on DIN EN ISO 15197Day 1Assessment of the analytical measurement performance of the blood glucose monitor

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026